My Lords, at this late hour, I draw noble Lords’ attention to the debate on the predecessor Bill on 4 February 2019, in which I made similar points to those that are reflected in the three amendments in my name in this group. Regarding what the noble Baroness, Lady Kramer, said, I do not think Amendments 104A and 108A are tidying up. They are there to delete the possibility that the chief executive of the Trade Remedies Authority might be appointed by the Secretary of State in the first instance where the chair of the Trade Remedies Authority has not been appointed.
We are in a situation where, if the Bill were to pass into law before the end of the year and if it were to be commenced rapidly, we already have a chair designate of the Trade Remedies Authority. We happen not to have a chief executive designate. We are in the unhappy position where the Trade Remedies Authority has been legislated for for a couple of years but has not actually existed because this Bill was supposed to have become law alongside the Taxation (Cross-border Trade) Act. In that time, it has had a chair designate, who then stood down to be replaced in February this year, and a chief executive designate, who stood down in April this year and has not been replaced, so it is not a happy story so far. We cannot have a situation where the first chief executive of the body proper is not appointed by the chair designate who is in place, and I see no reason why that provision of Schedule 4(2) should not now be taken out and, as a consequence of that, paragraphs 17 to 23 of Schedule 4 can be removed since they all relate to that possibility.
As the noble Baroness, Lady Kramer, said, what is more important is the issue of the appointment of the chair and that, in order to reflect the importance of the role and the impact it can have in the public domain —including, obviously, from a business point of view, the economic domain in particular—and because of the requirement for independence, this should be an appointment where, before it is made, the Secretary of State should seek the views of the International Trade Select Committee in the other place.
Interestingly, I have asked the chair of the International Trade Select Committee in the Commons whether it has seen the chair designate of the Trade Remedies
Authority and, as of last week, it had not. It seems to me that the department has been somewhat remiss not to put the chair designate in front of the Select Committee and to seek its views, and, not least because we had this debate back in 2019, it could easily have done it when it came to appoint a new chair designate in 2020. However, it has chosen not to do so. I think that the time has now come for Ministers to agree that this role should be one where the Secretary of State takes the views of the Select Committee before making the appointment.